chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rashes:  left breast approximately 3 inches by 3 inches, left thigh approximately 2 inches by 2 inches
red rash patch on face; patient did not feel good; red rash patch on face; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Heart rate went up), BLOOD PRESSURE INCREASED (Blood pressure up to 146), RASH (red rash patch on face), RASH ERYTHEMATOUS (red rash patch on face) and MALAISE (patient did not feel good) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included METOPROLOL for Blood pressure, ATORVASTATIN for Cholesterol, MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC) for Supplementation therapy.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced HEART RATE INCREASED (Heart rate went up), BLOOD PRESSURE INCREASED (Blood pressure up to 146), RASH (red rash patch on face) and MALAISE (patient did not feel good). On an unknown date, the patient experienced RASH ERYTHEMATOUS (red rash patch on face). At the time of the report, HEART RATE INCREASED (Heart rate went up), BLOOD PRESSURE INCREASED (Blood pressure up to 146), RASH (red rash patch on face), RASH ERYTHEMATOUS (red rash patch on face) and MALAISE (patient did not feel good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment given included Benadryl.
Vaccine injection site cellulitis; Was diagnosed in ER, arm red/warm/swollen and painful; treated with course of oral antibiotics.
Initial report received on 12 October 2007 from a health care professional.  A 25-year-old female patient had received a first dose, left deltoid, intramuscular injection of Adacel, lot number C2844AA, on 05 October 2007.  Two days later, the patient developed cellulitis at the site of the vaccination.  She was treated with Keflex.  At the time of this report, the patient had recovered.
This spontaneous report as received from a pharmacist refers to a 55 years old male patient with none pertinent medical history or drug reactions/allergies. On 07-AUG-2012 the patient was vaccinated with ZOSTAVAX (lot # 0365AE, exp. date. 23-APR-2013, 0.65 ml, once, subcutaneous) because of doctor recommendation. Concomitant therapies included LIPITOR. On approximately 28-AUG-2013 (reported as about 3 weeks after receiving ZOSTAVAX) the patient experienced shingles-like rash. The patient did not seek any medical attention in regards to the reaction. No treatment given. The shingles-like rash cleared up a couple days later, on an unknown date in 2013. The patient did not seek medical attention, no treatment was given for shingles-like rash and none lab diagnostic tests were performed. The relatedness between ZOSTAVAX and shingles-like rash was not reported. Additional information has been requested.
DEVELOPED HEADACHE, BODY ACHE, AND FATIGUE LASTING 24 HOURS.
Injection site was warm; Sore injection site right arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH and VACCINATION SITE PAIN in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced VACCINATION SITE WARMTH and VACCINATION SITE PAIN. At the time of the report, VACCINATION SITE WARMTH and VACCINATION SITE PAIN outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Concomitant medications were provided by the reporter. No Treatment information was reported.   This case was linked to MOD-2021-371373, MOD-2021-369457 (Patient Link).
loss of sight in his eyes; Soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of BLINDNESS (loss of sight in his eyes) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness around the injection site). On 31-Mar-2021, the patient experienced BLINDNESS (loss of sight in his eyes) (seriousness criterion medically significant). At the time of the report, BLINDNESS (loss of sight in his eyes) and VACCINATION SITE PAIN (Soreness around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event of vaccination site pain, a causal relationship cannot be excluded. However,very limited information regarding the event of Blindness has been provided at this time.  Further information has been requested.
Darkened extremities; abnormal "strange" respirations; Axillary temp 99.4, increased fussy; Approx 2 hrs p/immun went to ER placed in Hosp overnight under mist tent & monitor. Dismissed w/rx for Ceclor.
INJECTION SITE PAIN, REDNESS, ITCHING, SWOLLEN, WARM TO TOUCH, RAISED EDGES. TODAY IS DAY 9 POST INJECTION AND THE INFLAMMATION SITE ON THE LEFT ARM IS EXPENDING.  ALSO ITCHY ALL OVER THE BODY INCLUNGING SCALP
SECOND DOSE OF PFIZER COVID VACCINE WAS ADMINISTERED 14 DAYS FROM THE FIRST DOSE
Patient presented to the ER due to rectal bleeding. He was incidentally found COVID-19 positive. He remained asymptomatic during his hospital stay.
This case was reported by a physician via call center representative and described the occurrence of laceration of finger in a adult female patient who received ROTARIX lyophilized formulation (batch number GB374, expiry date 24th February 2019). On an unknown date, the patient received ROTARIX lyophilized formulation. On an unknown date, immediately after receiving ROTARIX lyophilized formulation, the patient experienced laceration of finger and pharmaceutical product complaint. On an unknown date, the outcome of the laceration of finger and pharmaceutical product complaint were unknown. Additional details were provided as follows: The healthcare professional called and reported a defective ROTARIX vaccine. The vial was cracked at the bottom and when the nurse tried to pull the vial out of the box, it shattered and also cut her on the finger. The caller stated that they have not dropped the package, and if it was dropped, it was before they received it. The blister try nor the carton was damaged. She stated that there were a few spots in the package, but did not know if it was leakage or powder from the vial. She stated that there were pieces of glass in the vial, they stored the vaccine in a vaccine-dedicated refrigerator, and she did not know if there was still any product in the vial. She would send pictures to the email provided. The healthcare professional would send defective product back. Credit Request Template completed to arrange credit.
Pt recvd 1st dose of Hep B vax 28NOV89 & exp fatigue & awakened in  morning w/ disseminated arthralgias. Pt recovered after 1 week.
I recieved the Flu shot on 15 Sep 2009.  Ibegan breaking out with a severe rash all over my body.,  This first began to appear on September 17th,...Went to see my doctor on September 18th for treatment.
I contracted COVID-19 on 06/08/2022 with symptoms of congestion, and dry cough. I was prescribed PAXLOVID on 06/11/2022 at the urgent care. I was ill for 18 days before my symptoms fully resolved. I had also continued to test positive until 06/22/2022. I am fully recovered now with no lingering symptoms.
Severe Nausea, Some Vomit, Stomach Upset, Stomachache, Mild but continuous Dizziness, Severe Fatigue, Muscle Weakness
12 year old received a 1st Pfizer .2 mm dose  for a 5 to 11 year old.
DTaP #5 given on 8/30/07; on 8/31/07 the DTaP site became red from top of shoulder to just above elbow (4 3/4" long), local pallor, no fever, no c/o local discomfort, no limited range of motion, no decreased activity; the upper arm was swollen 9" circumference vs non-affected arm of 7 1/4" circumference.
shortness of breath, tightness in chest feeling for about 12 hours. Started 36 hours after second dose.
Approximately 2 hours after flu shot patient's (L) eye was swollen shut and (R) eye was watering. He did not take any medication or seek medical attention. The next am the swelling in eye was gone.
Blepharitis- antibiotic cream and warm compresses - itching and scaling returned a little after treatment concluded - advised dermatologist on regular visit and she prescribed a steroid cream which cleared up, but condition comes back.
left arm is itchy; red spot bigger than a golf ball; barely tender; hard knot at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (left arm is itchy), ERYTHEMA (red spot bigger than a golf ball), TENDERNESS (barely tender) and VACCINATION SITE INDURATION (hard knot at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (left arm is itchy), ERYTHEMA (red spot bigger than a golf ball), TENDERNESS (barely tender) and VACCINATION SITE INDURATION (hard knot at injection site). At the time of the report, PRURITUS (left arm is itchy), ERYTHEMA (red spot bigger than a golf ball), TENDERNESS (barely tender) and VACCINATION SITE INDURATION (hard knot at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided by the reporter.
This spontaneous case, initially received from other non-healthcare professional (consumer) on 11-Jul-2018, concerns a 68-year-old, elderly, female patient. The patient's current condition included high cholesterol (reported as medical history) (since an unspecified date). The patient's concomitant medications included LIVALO for cholesterol and ZANTAC for an unknown indication. On 02-Feb-2018, the patient was administered FLUAD [dose: 0.5 ml, anatomical location: left arm, route of administration, batch number and expiry date: not reported]. On the same day, immediately after vaccination, the patient experienced pain at injection site and nausea for few hours. No bruising or swelling were observed. On an unspecified date in 2018, the patient experienced extreme pain and was unable to scratch her back. Patient consulted a cardiologist and was advised to visit her primary care physician (PCP). Patient was given antibiotics (unspecified). It was reported that, the patient's condition had worsened a little over the time. At the time of this report, the patient had not recovered from the events. The reporter assessed the case as non-serious.
SHORTNESS OF BREATH, EXCESSIVE TIREDNESS, HEADACHE, BLURRY VISION, FEVER, NIGHT SWEATS LASTING 3 DAYS.
An area 2- 3 inches square right below the injection site is slightly red, raised, and sensitive to touch, more than 48 hours after I had the injection. Hopefully it will be better tomorrow. I've been taking 2 Bayer aspirin at least twice a day. I understand from what I read on line that this is the most common "adverse reaction" so I'm more annoyed than alarmed. But I thought I'd report it since it is considered an adverse reaction, albeit nothing too acute.
Narrative: 90 yo pt had received covid vaccinations on 1/13/2021 & 2/24/2021. Pt died at home with home hospice on 5/29/2021 after decision made for comfort care only, Family did not want the patient to have any further hospitalizations, No ER visits, no IVAB, No dialysis. The agree that they want him comfortable and to pass in his home. Pt with hx of dementia, SVT,HTN,GERD, HBP, dysphagia and had stopped eating & urinating several weeks prior to death when decided to go to hospice care. Likely death is not related to covid vaccinations
arm is completely abnormally swollen; it is hot; hard to the touch; had some swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm is completely abnormally swollen), VACCINATION SITE WARMTH (it is hot), VACCINATION SITE INDURATION (hard to the touch) and VACCINATION SITE SWELLING (had some swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE SWELLING (had some swelling). On 27-Jan-2021, the patient experienced PERIPHERAL SWELLING (arm is completely abnormally swollen), VACCINATION SITE WARMTH (it is hot) and VACCINATION SITE INDURATION (hard to the touch). At the time of the report, PERIPHERAL SWELLING (arm is completely abnormally swollen), VACCINATION SITE WARMTH (it is hot), VACCINATION SITE INDURATION (hard to the touch) and VACCINATION SITE SWELLING (had some swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.; Reporter's Comments: This case concerns a female of unknown age who experienced NS unexpected events of peripheral swelling, vaccination site warmth and NS expected events of vaccination site swelling, vaccination site induration.  Event onset occurred the same days as the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
sick; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick) and PYREXIA (low grade fever) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included Splenectomy (splenectomy) and Appendectomy (appendix taken out.). Concurrent medical conditions included Immune system disorder (weak immune system), Liver damage (liver disease), Hypertension (hypertension) and Diabetic (diabetic).   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick) and PYREXIA (low grade fever). At the time of the report, ILLNESS (sick) and PYREXIA (low grade fever) had resolved.            Patient stated that Four weeks ago patient had a flu shot. He mentioned other ailments he had which make him at risk of severe COVID. It's been over 8 months and he was worried for his protection against COVID. He contacted hi local health department and all they have is Pfizer.  No concomitant medications were provided. Patient took sports drink for his adverse event.
patient got the wrong vaccine he should of received a Tdap / no reaction / we did call patient back in to receive the Tdap vaccine
7cmx9cm red area to left upper arm. Treated with Benadryl.
PATIENT CALLED STATING SHE FELT VERY LIGHT HEADED AND ALMOST FAINT. SHE DESCRIBES HER SYMPTOMS LIKE FLU-LIKE , LOSS OF APPETITE
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 11-JUN-2015, the patient was inoculated with the ZOSTAVAX vaccine as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot number not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. Later in 2015, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown.  Causality assessment was related. Additional information has been requested.
Dose of Covid 19 vaccine given 24 hours after initial vial puncture. No adverse reactions where noted by the patient.
02/05/03 left arm redness and swelling out pain after receiving Pheumovax 02/04/2003. Increased signs since then. Tx  Triameinolou cream, Predisone.
Received DTaP and IPV IM in RT Thigh on July 16, 2003 at 11:50am. Mother stated that child complained of leg hurting the am of July 18th. Child was seen 7:30pm July 18th as parents had noticed swelling of rt thigh and knee with a red raised rash. Child complained of pain with walking.
Helped fiance (military) change bandage from a dripping smallpox vaccine without using gloves.  Onset of 2 small blisters 11-17-04 on collar bone area.  11-18-04 onset of 1 small red raised bump on forearm and 1 on stomach.  Probable inadvertent inoculation of contact.
Patient reports that, within 10 minutes after receiving Flu vaccine her left thumb had became swollen, hardened to touch and had sharp cramping / pulsation which lasted approx. 10 minutes - then changed to a subtle discomfort and resolved completely within one hour.
Chest pain, Shortness of breath, Feelings of having a fast-beating, fluttering, or pounding heart. Patient had a cardiovascular reaction to the Pfizer vaccine #1 on 10/11/21. He is being referred urgently to cardiology for management of the PVC's detected on EKG and is still symptomatic at this time.
Upper right arm swollen,red, hot and itchy.  Body aches. Tiredness.
Patient obtained 1st dose Pfizer vaccine at 0915am. As per patient, she is to be monitored 45min to 1hour, instructed by her allergy doctor. At 10:36, medical alert was called. Patient was complaining of Headache and dizziness. Pain level of headache was a 9. 1037 BP 158*/68 HR 82 SAT 99%. Patient alert and oriented. 1042am BP 156/77 HR 74 Pain level 6. At 1046 BP 148/80 HR 77. Patient stated her headache was better. Patient left with her friend who was scheduled to pick her up. End time is 1047am.
Temperature excursion - CDC recommend Re-vax. Pt revaccinated on 11/03/2021.
Ventricular arrhythmia; Heart palpitations - ventricular arritmia; This is a spontaneous report from a contactable consumer (patient). A 43-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: 92EL9267) via unspecified route of administration on left arm on 11Feb2021 at 12:00 (at the age of 43 years) as single dose for COVID-19 immunisation. The patient had no medical history and allergy. The concomitant medications the patient received within 2 weeks of vaccination included Vitamin C and D. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Patient was not tested for COVID-19 since the vaccination. On 14Feb2021 at 00:00, the patient experienced heart palpita-tions - ventricular arrhythmia. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received amioadoron as treatment. The outcome of the events was unknown.
w/in 15 min of immun, pt devel papular rash on face & rt shoulder; pt was screaming @ that time;
Numbness in hand; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An 80-year-old female patient received BNT162b2 (BNT162B2), on 24Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 79 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EP6955), administration date: 22Mar2021, when the patient was 79-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 2, SINGLE, Lot number: EP6955), administration date: 19Apr2021, when the patient was 79-year-old, for Covid-19 Immunization. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "Numbness in hand". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: It was reported that, the patient took the Pfizer Covid-19 vaccine and then she got the virus this year and now she got over that but she had side effects from the virus. It kept on lingering. The husband could not use his right hand at all because of the numbness and the wife had the same thing but not as severe as husband.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201304945 same product/event, different patients;
Arm pain for 24 hours after injection. Flu like symptoms including high fever, and severe tiredness for 48 hours after vaccination, starting at 24 hours and lasting for 24 hours
Hives on arms across shoulders and on neck within 30min of injection. No difficulty breathing or swallowing. 50mg Benadryl taken, hives resolved, itching continued at injection site next day, no returning of hives noted
Vomiting and irritability on the night of vaccination 7/14/08.  Irritability and diarrhea on day 6-8 following vaccination.  Fever 101-105 started 7/18 continued through 7/25.  Petechial rash on 7/26-7/27.  Severe upper chest congestion on 7/24-7/26.  8/26/2008 Reviewed hospital medical records of 7/23- FINAL DX: No d/c summary available. Admitted for gastroenteritis & dehydration Records reveal patient experienced diarrhea x 1 week, dehydration, vomiting x 1 day,  irritability, fever, mottled skin, nasal congestion, rhinorrhea, tachycardia, pulse ox 93-94%.  Tx w/oxygen supplementatio & IVF.
Pt said his ankles were very painful right after getting the injection and the pain lasted approx. 24 hrs.
Sluggish; Tired; Hungry; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 39 year-old male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SLUGGISHNESS (non-serious), outcome "unknown", described as "Sluggish"; FATIGUE (non-serious), outcome "unknown", described as "Tired"; HUNGER (non-serious), outcome "unknown", described as "Hungry". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.